巴克莱在财报季前降级Lumentum(LITE.US)等三只半导体股,转而“增持”科磊(KLAC.US)

智通财经
Oct 21

智通财经APP获悉,在财报季开启前夕,巴克莱银行对多家半导体相关公司评级作出重要调整。该机构将Lumentum(LITE.US)、Astera Labs(ALAB.US)及迈威尔科技(MRVL.US)三家公司的评级从"增持"下调至"持股观望",核心逻辑在于相较其他已切入AI赛道的个股,这三家公司的吸引力有所下降。巴克莱特别指出更看好科磊(KLAC.US)、Coherent(COHR.US)和 MACOM Technology Solutions(MTSI.US)的投资价值。

具体来看,Lumentum此轮评级调整前,其股价在过去三个月已累计上涨60%,远超同期标普500指数5%的涨幅。分析师汤姆·奥马利在客户报告中强调:"我们暂时不继续看好Lumentum的评级,因为其风险回报状况相较于同行已不再具备明显优势。尽管存在EML产能扩张和光收发器客户带来的潜在上行空间,但在估值门槛已然抬高的情况下,上述增长催化剂带来的上行空间相对有限。"

Astera Labs评级下调则源于其UALink产品的市场渗透不足——除亚马逊Trainium 3项目外,该产品尚未在更广泛的以太网、ESUN及SUE-T产品体系中建立显著优势,同时行业正向Ethernet、ESUN及SUE-T方案迁移,UALink面临被边缘化的风险。而迈威尔科技被调低评级的原因在于其专用集成电路业务表现弱于最初预期,同时数据中心业务面临额外的市场风险。

值得注意的是,巴克莱此次调整并非全面看空半导体板块。该机构同步将半导体设备领军者科磊(KLAC.US)的股票评级上调至"增持",并指出:"我们对过程控制强度提升的长期前景及科磊在行业领先领域的业务布局持乐观态度。随着中国以外市场收入增长门槛相对较低,预计公司未来将迎来强劲增长周期。"

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10